Biggest News Aggregation in the World
📰 Nasdaq Caba News

Page 2 - Nasdaq Caba News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Caba. Real-time updates on events, politics, business and more.

Cabaletta Bio (NASDAQ:CABA) Trading Up 7.1%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) shares shot up 7.1% during trading on Thursday . The stock traded as high as $22.08 and last traded at $21.95. 216,444 shares were traded during trading, a decline of 73% from the average session volume of 788,854 shares. The stock had previously closed at $20.50. Analyst […]
Stifel Nicolaus Gwendolyn Binder William Blair Dynamic Technology Lab Private Ltd Cabaletta Bio Inc York Mellon Corp

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Target Price at $27.64

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average recommendation of “Buy” from the ten analysts that are covering the firm, MarketBeat reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in the last year […]
Stifel Nicolaus Gwendolyn Binder William Blair Dynamic Technology Lab Private Ltd Comerica Bank Morgan Stanley

Short Interest in Cabaletta Bio, Inc. (NASDAQ:CABA) Increases By 12.1%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 5,670,000 shares, an increase of 12.1% from the November 15th total of 5,060,000 shares. Based on an average trading volume of 1,150,000 shares, the short-interest ratio is presently 4.9 […]
William Blair Stifel Nicolaus Gwendolyn Binder Redmile Group Bain Capital Life Sciences Investors Fred Alger Management

Short Interest in Cabaletta Bio, Inc. (NASDAQ:CABA) Drops By 19.4%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 5,060,000 shares, a decline of 19.4% from the October 31st total of 6,280,000 shares. Based on an average trading volume of 788,600 shares, the days-to-cover ratio is presently 6.4 […]
Stifel Nicolaus Gwendolyn Binder Cabaletta Bio Company Profile Fred Alger Management Cabaletta Bio Inc Morgan Stanley

Cabaletta Bio (NASDAQ:CABA) Coverage Initiated at William Blair

William Blair assumed coverage on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report issued on Wednesday, Briefing.com reports. The firm issued an outperform rating and a $38.00 price target on the stock. Several other equities analysts also recently weighed in on CABA. Guggenheim reaffirmed a buy rating and issued a $34.00 price […]
Stifel Nicolaus Gwendolyn Binder William Blair Manufacturers Life Insurance Company Wells Fargo Company Comerica Bank

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cabaletta Bio (NASDAQ:CABA) Stock Price Down 4.2%

Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) traded down 4.2% during trading on Monday . The company traded as low as $17.17 and last traded at $17.20. 167,698 shares changed hands during trading, a decline of 70% from the average session volume of 560,050 shares. The stock had previously closed at $17.96. […]
United States Stifel Nicolaus Gwendolyn Binder Cabaletta Bio Inc Victory Capital Management Inc Wells Fargo Company

Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $50.00

Cabaletta Bio (NASDAQ:CABA – Free Report) had its price target raised by Cantor Fitzgerald from $40.00 to $50.00 in a research report sent to investors on Wednesday, Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock. Several other equities research analysts also recently weighed in on CABA. Stifel Nicolaus started coverage on […]
Gwendolyn Binder Stifel Nicolaus Fred Alger Management Redmile Group Cabaletta Bio Inc Wells Fargo Company

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of "Buy" from Brokerages

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned an average recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the […]
Gwendolyn Binder Stifel Nicolaus Securities Exchange Commission Bain Capital Life Sciences Investors Cabaletta Bio Company Profile Cabaletta Bio Inc
Source: wkrb13.com

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $21.00

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have updated their coverage on the stock in the […]
Gwendolyn Binder Securities Exchange Commission Vanguard Group Inc Cabaletta Bio Inc York Mellon Corp Renaissance Technologies
Source: wkrb13.com

Cabaletta Bio (NASDAQ:CABA) Stock Rating Reaffirmed by HC Wainwright

Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $17.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 9.32% from the stock’s current price. A number of […]
Gwendolyn Binder Ameritas Investment Partners Inc Wells Fargo Company Envestnet Asset Management Inc Advisor Group Holdings Inc Barclays Plc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science